courtesy of Jon OggStocks were indicated to open higher on Monday after hitting all-time highs the prior week. The one trend that has been proven time after time in this eight-year bull…
The top analyst upgrades, downgrades and other research calls from Wednesday include Axovant, Carnival, Micron Technology, Nike, SunPower, Vivint Solar and Walgreens.
The top analyst upgrades, downgrades and other research calls from Thursday include AMD, Biogen, Capital One, Intuit, Jinko Solar, Micron Technology, Albermarle and Alnylam Pharmaceuticals.
Alnylam Pharmaceuticals saw its shares make a handy gain on Wednesday after the firm gave an update on its late-stage trial in patients with hereditary ATTR amyloidosis with polyneuropathy.
The top analyst upgrades, downgrades and other research calls from Tuesday include Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess and Western Digital.
Jefferies has picked out a few companies in the biotech industry that stand to win big over the coming year.
The top analyst upgrades, downgrades and other research calls from Friday include Analog Devices, Camping World, Ciena, Deere, RSP Permian, Ulta Beauty and Yum China.
The the top analyst upgrades, downgrades and other research calls from Tuesday include AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy and Yum Brands.
The top analyst upgrades, downgrades and initiations seen from Monday include Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald's and Snap.
The top analyst upgrades, downgrades and initiations include ConocoPhillips, Goodyear Tire, Humana, Lululemon Athletica and Range Resources.
It seems that analysts are taking the forefront and making calls on where the biopharma industry is going ahead of action by the Trump administration.
Chris Lange A series of new Jefferies reports focus on four biotech stocks that have big upside potential, regardless of the political chatter.
Here are some of the companies that reported notable insider buying last week, including Cheniere Energy and Lands' End.
Jefferies highlights top growth stocks to buy each week, and this week is no exception. These four all make good sense now and have outstanding upside potential.
The late-summer doldrums are over and the markets are on the move again as we are now in the fourth quarter. But a few companies held the market back from pushing even…
Chris Lange 
